| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cortical microtubule | 1.75e-05 | 3 | 51 | 2 | GO:0055028 | |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 5.81e-05 | 5 | 51 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | microtubule organizing center | 3.40e-04 | 919 | 51 | 9 | GO:0005815 | |
| GeneOntologyCellularComponent | centrosome | 5.11e-04 | 770 | 51 | 8 | GO:0005813 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 6.85e-04 | 16 | 51 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | spindle microtubule | 1.21e-03 | 86 | 51 | 3 | GO:0005876 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.46e-03 | 201 | 51 | 4 | GO:0072686 | |
| MousePheno | abnormal susceptibility to atherosclerosis | 2.72e-05 | 19 | 44 | 3 | MP:0005340 | |
| Domain | LRRNT | 6.31e-06 | 98 | 50 | 5 | IPR000372 | |
| Domain | LRRNT | 6.31e-06 | 98 | 50 | 5 | SM00013 | |
| Domain | Leu-rich_rpt_typical-subtyp | 7.48e-06 | 177 | 50 | 6 | IPR003591 | |
| Domain | LRR_TYP | 7.48e-06 | 177 | 50 | 6 | SM00369 | |
| Domain | LRR | 1.54e-05 | 201 | 50 | 6 | PS51450 | |
| Domain | LRR_1 | 2.51e-05 | 219 | 50 | 6 | PF00560 | |
| Domain | Leu-rich_rpt | 8.21e-05 | 271 | 50 | 6 | IPR001611 | |
| Domain | LRR_8 | 9.21e-05 | 171 | 50 | 5 | PF13855 | |
| Domain | - | 2.07e-04 | 321 | 50 | 6 | 3.80.10.10 | |
| Domain | L_dom-like | 2.32e-04 | 328 | 50 | 6 | IPR032675 | |
| Domain | LRRNT | 3.85e-04 | 53 | 50 | 3 | PF01462 | |
| Domain | Cys-rich_flank_reg_C | 1.80e-03 | 90 | 50 | 3 | IPR000483 | |
| Domain | LRRCT | 1.80e-03 | 90 | 50 | 3 | SM00082 | |
| Domain | Myosin_head_motor_dom | 4.64e-03 | 38 | 50 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.64e-03 | 38 | 50 | 2 | PS51456 | |
| Domain | Myosin_head | 4.64e-03 | 38 | 50 | 2 | PF00063 | |
| Domain | MYSc | 4.64e-03 | 38 | 50 | 2 | SM00242 | |
| Pathway | BIOCARTA_SLRP_PATHWAY | 1.17e-04 | 6 | 40 | 2 | MM1581 | |
| Pathway | BIOCARTA_SLRP_PATHWAY | 1.17e-04 | 6 | 40 | 2 | M22071 | |
| Pathway | PID_FRA_PATHWAY | 1.54e-04 | 37 | 40 | 3 | M65 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26663310 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23412898 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19036156 | ||
| Pubmed | Quantitative analysis of type I collagen fibril regulation by lumican and decorin using AFM. | 2.28e-06 | 2 | 53 | 2 | 23747391 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28789706 | ||
| Pubmed | 3.00e-06 | 591 | 53 | 8 | 15231748 | ||
| Pubmed | Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly. | 6.83e-06 | 3 | 53 | 2 | 25886697 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25304290 | ||
| Pubmed | Pancreatic tumor cells influence the composition of the extracellular matrix. | 6.83e-06 | 3 | 53 | 2 | 15336555 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 28459201 | ||
| Pubmed | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. | 6.83e-06 | 3 | 53 | 2 | 29867136 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19616852 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 16902402 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 9922406 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 20357198 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 10656267 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 30002123 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 11878934 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 18620607 | ||
| Pubmed | Genes encoding proteoglycans are associated with the risk of anterior cruciate ligament ruptures. | 2.27e-05 | 5 | 53 | 2 | 24552666 | |
| Pubmed | The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. | 2.27e-05 | 5 | 53 | 2 | 23331954 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 9439574 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 14557068 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 17558846 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 14550773 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 24272803 | ||
| Pubmed | Differential expression of Slitrk family members in the mouse nervous system. | 3.40e-05 | 6 | 53 | 2 | 19924824 | |
| Pubmed | 3.57e-05 | 407 | 53 | 6 | 12693553 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 23345436 | ||
| Pubmed | Distinct modes of cell competition shape mammalian tissue morphogenesis. | 4.76e-05 | 7 | 53 | 2 | 31092920 | |
| Pubmed | N-myc regulates growth and fiber cell differentiation in lens development. | 4.76e-05 | 7 | 53 | 2 | 28716713 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 20360993 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 25715693 | ||
| Pubmed | 9.72e-05 | 58 | 53 | 3 | 23284291 | ||
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 1.24e-04 | 11 | 53 | 2 | 20696843 | |
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 12796502 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 32160556 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.29e-04 | 363 | 53 | 5 | 14691545 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 22115758 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 26876178 | ||
| Pubmed | An Alternative Splicing Program for Mouse Craniofacial Development. | 4.70e-04 | 21 | 53 | 2 | 33013468 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.97e-04 | 430 | 53 | 5 | 35044719 | |
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 38736483 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 5.18e-04 | 934 | 53 | 7 | 33916271 | |
| Pubmed | Detection of genes regulated by Lmx1b during limb dorsalization. | 5.65e-04 | 23 | 53 | 2 | 22417325 | |
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 36973253 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 22792062 | ||
| Pubmed | 6.16e-04 | 689 | 53 | 6 | 36543142 | ||
| Pubmed | 6.20e-04 | 963 | 53 | 7 | 28671696 | ||
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 21307096 | ||
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 7.23e-04 | 26 | 53 | 2 | 30923192 | |
| Pubmed | 7.50e-04 | 116 | 53 | 3 | 30652415 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.19e-04 | 283 | 53 | 4 | 30585729 | |
| Pubmed | 9.19e-04 | 493 | 53 | 5 | 15368895 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.53e-04 | 497 | 53 | 5 | 36774506 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.02e-03 | 759 | 53 | 6 | 35915203 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.09e-03 | 1061 | 53 | 7 | 33845483 | |
| Pubmed | 1.17e-03 | 33 | 53 | 2 | 18424556 | ||
| Pubmed | 1.46e-03 | 146 | 53 | 3 | 21399614 | ||
| GeneFamily | Small leucine rich repeat proteoglycans | 1.40e-04 | 12 | 27 | 2 | 573 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.70e-06 | 197 | 53 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 3.89e-06 | 199 | 53 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-06 | 200 | 53 | 5 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.99e-05 | 170 | 53 | 4 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-05 | 172 | 53 | 4 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.46e-05 | 174 | 53 | 4 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-05 | 179 | 53 | 4 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 6.09e-05 | 179 | 53 | 4 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-05 | 179 | 53 | 4 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-05 | 179 | 53 | 4 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 6.09e-05 | 179 | 53 | 4 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.36e-05 | 181 | 53 | 4 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.36e-05 | 181 | 53 | 4 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.36e-05 | 181 | 53 | 4 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.50e-05 | 182 | 53 | 4 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 6.92e-05 | 185 | 53 | 4 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 186 | 53 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 186 | 53 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.37e-05 | 188 | 53 | 4 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.52e-05 | 189 | 53 | 4 | 6687a93ac8540ece5fd762f6f77c1f25f159195b | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 7.52e-05 | 189 | 53 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-05 | 189 | 53 | 4 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 190 | 53 | 4 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.68e-05 | 190 | 53 | 4 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 191 | 53 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.83e-05 | 191 | 53 | 4 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.15e-05 | 193 | 53 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.32e-05 | 194 | 53 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.32e-05 | 194 | 53 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.49e-05 | 195 | 53 | 4 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.49e-05 | 195 | 53 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.83e-05 | 197 | 53 | 4 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.83e-05 | 197 | 53 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.18e-05 | 199 | 53 | 4 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 1d67c5d2c617749b521e70879950dea2c9d076d6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.36e-05 | 200 | 53 | 4 | 26c7f2b0afe9e50f2a5c43918ad8e91d7553b72c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-04 | 109 | 53 | 3 | 0d4128af237afcc0adb4dfdd206fa3ddbe5b0e86 | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.75e-04 | 128 | 53 | 3 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-04 | 129 | 53 | 3 | 6abdba987c8528f7cb90b32dc01796e02c7352c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 132 | 53 | 3 | 97e7d5f7086c6213aec4eaa581bc182338189029 | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.43e-04 | 134 | 53 | 3 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 6.16e-04 | 140 | 53 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-VLMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-04 | 145 | 53 | 3 | 7d90d95dc80b7d6230bc24ef6a524a8bb243a65e | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-04 | 145 | 53 | 3 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-VLMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-04 | 145 | 53 | 3 | 18e958b7435fb4d7384f4ad5ab31d7a464a55eb9 | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 7.10e-04 | 147 | 53 | 3 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.53e-04 | 150 | 53 | 3 | 408b7c2c3a42f5455c8c26a83d9e366a1c8d5ecc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.53e-04 | 150 | 53 | 3 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.28e-04 | 155 | 53 | 3 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 157 | 53 | 3 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-04 | 157 | 53 | 3 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 157 | 53 | 3 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.75e-04 | 158 | 53 | 3 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.91e-04 | 159 | 53 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-04 | 161 | 53 | 3 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-04 | 162 | 53 | 3 | dd4a08af653095ad4f63112312715589a1d43b38 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | b4adb9c053e02e71b0f1a6e7ab6dddc34a7245e0 | |
| ToppCell | droplet-Heart-4Chambers|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | 5625ec6dae204d5537883f05ea546970628d10bb | |
| ToppCell | facs-Thymus-Flowthrough-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | ebce09d96e02820ce7d33ad3f417586f96efed76 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 162 | 53 | 3 | 96c8ed9d9cb1cf4175c2f41a6e4ebe02a378044c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 9.57e-04 | 163 | 53 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 163 | 53 | 3 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-HSC/ELP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.74e-04 | 164 | 53 | 3 | 3c07d8f53511f269540bf032738a4ada35650b18 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-04 | 164 | 53 | 3 | 72ef807895385ba23e30d19d12b1b0549a699690 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-04 | 164 | 53 | 3 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-04 | 164 | 53 | 3 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-04 | 165 | 53 | 3 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-03 | 166 | 53 | 3 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-03 | 166 | 53 | 3 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-03 | 166 | 53 | 3 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 167 | 53 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-03 | 167 | 53 | 3 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 1.03e-03 | 167 | 53 | 3 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-03 | 167 | 53 | 3 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.04e-03 | 168 | 53 | 3 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-03 | 168 | 53 | 3 | e4af12f06f4878b7910272bf7c1d9c2f9af99bf8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 169 | 53 | 3 | 1558606be0a8bcd4fd0ce609701a1411e4ca2f9f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 169 | 53 | 3 | 1b2354de1ce4080118d9f01e7c5fd6079e705125 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.06e-03 | 169 | 53 | 3 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 170 | 53 | 3 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-03 | 170 | 53 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 1.08e-03 | 170 | 53 | 3 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 170 | 53 | 3 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 171 | 53 | 3 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-03 | 171 | 53 | 3 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-03 | 171 | 53 | 3 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 1.12e-03 | 172 | 53 | 3 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 1.12e-03 | 172 | 53 | 3 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-03 | 172 | 53 | 3 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-03 | 172 | 53 | 3 | 1171e754fd503a0c1152162fcc12a115088a08c7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-03 | 172 | 53 | 3 | 2b0333c21b7472194a7b9feb3de121da3340fc5b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 173 | 53 | 3 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | droplet-Heart-4Chambers-21m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 174 | 53 | 3 | f098778ea74012861ec74b425e45776a31f67679 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-03 | 174 | 53 | 3 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 174 | 53 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.16e-03 | 174 | 53 | 3 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.19e-03 | 176 | 53 | 3 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| Disease | lumican measurement | 1.82e-05 | 4 | 52 | 2 | EFO_0021889 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 2.35e-04 | 13 | 52 | 2 | C0238288 | |
| Disease | influenza A (H1N1) | 4.93e-04 | 87 | 52 | 3 | EFO_1001488 | |
| Disease | urinary uromodulin measurement | 6.57e-04 | 96 | 52 | 3 | EFO_0005663 | |
| Disease | progression free survival, ovarian serous carcinoma | 6.88e-04 | 22 | 52 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Adenoid Cystic Carcinoma | 7.40e-04 | 100 | 52 | 3 | C0010606 | |
| Disease | triacylglycerol 50:2 measurement | 1.37e-03 | 31 | 52 | 2 | EFO_0010409 | |
| Disease | hip bone mineral density | 1.44e-03 | 126 | 52 | 3 | EFO_0007702 | |
| Disease | differentiated thyroid carcinoma | 1.75e-03 | 35 | 52 | 2 | EFO_1002017 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.31e-03 | 315 | 52 | 4 | EFO_0004612, EFO_0008591 | |
| Disease | unipolar depression, bipolar disorder | 2.65e-03 | 156 | 52 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 3.13e-03 | 47 | 52 | 2 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | cognitive inhibition measurement | 3.53e-03 | 50 | 52 | 2 | EFO_0007969 | |
| Disease | birth weight, parental genotype effect measurement | 4.74e-03 | 192 | 52 | 3 | EFO_0004344, EFO_0005939 | |
| Disease | Skin Neoplasms | 4.89e-03 | 59 | 52 | 2 | C0037286 | |
| Disease | Malignant neoplasm of skin | 4.89e-03 | 59 | 52 | 2 | C0007114 | |
| Disease | uterine fibroid | 5.24e-03 | 199 | 52 | 3 | EFO_0000731 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 5.31e-03 | 200 | 52 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | cancer | 5.39e-03 | 400 | 52 | 4 | MONDO_0004992 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKLQNLLKNGKTINL | 81 | Q14146 | |
| LQVKNNIKASLHNVK | 311 | A8K979 | |
| KHLQDDNNLLKQQLK | 776 | Q7Z7A1 | |
| IQQQLAKIHNNVKKL | 41 | Q8NEF3 | |
| NLEGKIIQQKLLKNN | 491 | Q86SQ4 | |
| LQHLDKNNLKKLKSQ | 51 | Q7Z2Y8 | |
| KGLKQQQQQHKKLLA | 321 | Q49A92 | |
| EHQNLQGKKKLCNLR | 471 | A6NC57 | |
| VLIKGLKQLHENQKN | 401 | Q9Y222 | |
| HSKKALKQALKQQQQ | 161 | Q76L83 | |
| NTHALGLAKKNKRNL | 96 | Q8WWL7 | |
| KTVQNLSKVQHQKLG | 2096 | Q8IWI9 | |
| QLQKNGLRKNGILKN | 421 | Q86WP2 | |
| KDAKKHNLGINNNNI | 261 | Q8N5G2 | |
| HSQNTGLLNQKKKLE | 1766 | A7E2Y1 | |
| FKNLKNLHALILVNN | 101 | P07585 | |
| KTLLGLQGLNQKANK | 41 | O95843 | |
| AKQHNLVGKKRAQLA | 176 | A8MTQ0 | |
| ANLKHNQQLEKKKNA | 766 | O15083 | |
| QANLTHQKKKLEGQI | 71 | P78380 | |
| KQLHQLLPNHVLQKK | 491 | P51003 | |
| KKLKNLNTLLLNNNH | 71 | A1KZ92 | |
| NILGKVKTLQQQLGK | 31 | Q6ZU35 | |
| HKLLGNIKNVAKTAN | 41 | Q00688 | |
| KKLLSQHLKQLLSNQ | 876 | Q6ZUT9 | |
| QHLKQLLSNQPLTKK | 881 | Q6ZUT9 | |
| NHILKLSKLQGEQKK | 56 | B2RV13 | |
| KQLKKLHINHNNLTE | 116 | P51884 | |
| KAILKNHLDQNPQLQ | 851 | O75899 | |
| NKKKIVHFQLSIGNL | 2221 | Q9C0D2 | |
| LIKQKNELLSNNQHL | 2566 | Q02224 | |
| LAGLKQQAKEKQAQL | 521 | Q14980 | |
| KLQGGSILAHIQKQK | 126 | Q9BUB5 | |
| FNKLHKLKVLILNDN | 151 | Q8IW52 | |
| QHKDQYNLLKIQLGK | 696 | O60763 | |
| LQHFLSVLLNNKKNG | 406 | A5PLK6 | |
| GTLIKKFSQKHLQLN | 236 | Q96HV5 | |
| LQEKHQLLKQQLKDQ | 1016 | Q9H2G2 | |
| GIQNKDILKRNKNHL | 81 | Q5TEA6 | |
| IHKLQKGQIYKQGNL | 356 | Q86UY8 | |
| HLLKKKLLIQNGTAN | 161 | P49019 | |
| LQLKQLEKQQGQPKH | 371 | P07476 | |
| KKGKSHLAIVQKVNN | 466 | Q6P4Q7 | |
| LQEKKHINLTKLGLN | 696 | Q8N2E2 | |
| NLNKQEKIHTGGKLN | 286 | Q9UII5 | |
| QQAGFNLRKVNKHIK | 701 | Q9Y5T5 | |
| KLQARQQQLLKKIEH | 446 | P04198 | |
| QLVKRLHINNNKIKS | 106 | Q96PX8 | |
| KIEKLQQKIQLALQH | 441 | P35398 | |
| LKQLAIKKQQHIDNI | 76 | Q14142 | |
| KKNQQLKVGILHLGS | 6 | Q9HD64 | |
| DHLKQNNTAKLVKQL | 106 | Q96QC0 | |
| RSLQHQEKQKLNKGG | 71 | Q9P206 | |
| NLLKNLKHRFLQQKI | 161 | Q13459 | |
| QGKLKNAHNIINLLK | 1106 | Q5VU43 |